**Question:** All of the following are true for Kyasanur Forest Disease except: March 2012

A. Kyasanur Forest Disease (KFD) is a viral hemorrhagic fever caused by the Kyasanur Forest virus (KFDV), a member of the Orthobunyaviridae family.
B. The virus is transmitted to humans via the bite of an infected tick, particularly the Hyalomma ticks found in the Kyasanur Forest of Karnataka, India.
C. The incubation period for KFD is typically 4-14 days, although cases with incubation periods of up to 34 days have been reported.
D. The first KFD outbreak in India occurred in March 2012, resulting in the deaths of several people and prompting public health efforts to control the virus's spread.

**Correct Answer:** March 2012 (Option D)

**Core Concept:** Kyasanur Forest Disease (KFD) is a viral hemorrhagic fever caused by the Kyasanur Forest virus (KFDV), affecting humans through tick bites, especially Hyalomma ticks in the Kyasanur Forest of Karnataka, India.

**Why the Correct Answer is Right:** The correct answer, March 2012, is incorrect because KFD has been reported in India since the 1950s, with the first recorded outbreak occurring in 1957. The statement about the outbreak in March 2012 is not accurate, as the disease has been endemic in the region for decades.

**Why Each Wrong Option is Incorrect:**

A. Transmission via ticks (Option B) is a correct mode of infection, as the virus is transmitted to humans through tick bites, particularly Hyalomma ticks in the Kyasanur Forest.

B. Incubation period (Option C) is a correct aspect of KFD, as it typically has a range of 4-14 days, with some cases showing longer incubation periods up to 34 days.

**Clinical Pearl:** The KFDV is a member of the Bunyaviridae family, which includes other viral hemorrhagic fevers like Dengue, Crimean-Congo hemorrhagic fever, and Nipah virus. Understanding the clinical features, transmission, and incubation period of KFD helps medical students and physicians recognize the disease and initiate appropriate treatment and management strategies for patients presenting with fever, headache, abdominal pain, and hemorrhagic manifestations in a patient from the endemic region.